28 results
8-K
EX-10.1
IRME
IR-Med Inc.
28 Aug 24
IR-MED Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer
4:05pm
confidential and access will be limited and restricted to individuals with need to know or process that information for purposes relating to Executive’s … and/or may continue to develop, receive, or otherwise have access to confidential or proprietary information, which is of value to IR Med Ltd. (together
8-K
EX-10.1
IRME
IR-Med Inc.
10 Jun 24
Entry into a Material Definitive Agreement
4:05pm
time, is able to afford a complete loss of such investment.
(d) Access to Information. Such Purchaser acknowledges that it has had the opportunity … of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial
PRE 14A
pof4805
4 Oct 23
Preliminary proxy
5:57pm
CORRESP
nyyaa2
11 May 23
Correspondence with SEC
12:00am
DEF 14A
vlo9zp0 s60okh
28 Nov 22
Definitive proxy
12:36pm
8-K
EX-4.1
sqev2awqg gys
14 Apr 22
IR-Med Announces $3.2 Million Private Placement
4:05pm
10-K
e9x1q0ak
31 Mar 22
Annual report
4:49pm
424B3
r8nj9j
30 Dec 21
Prospectus supplement
1:25pm